This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation USA (OSI USA)
September 23-24, 2026 | Part of Biotech Week Boston
Hynes Convention CenterBoston, United States
Book Now
Menu
Book

Laurent Audoly
CEO at Prive Bio
Speaker

Agenda Sessions

  • Targeting Fibroinflammation to Modify Cardiorenal-Metabolic Disease in the Post-GLP-1 Era

    , 09:00
    View Session

  • Keynote Panel: Breaking Barriers: Addressing Pricing and Reimbursement Challenges in Obesity Therapeutics

    , 16:00
    View Session

At this event

Prev
Next
Robrecht Thoonen
Senior Director External Innovation, Diabetes, Obesity & Cardiometabolic
Eli Lilly

See Laurent at Obesity Science & Innovation USA (OSI USA)

Book Now